B-luc EL4_Biocytogen Pharmaceuticals (Beijing) Co., Ltd._Biocytogen,drug development,antibody discovery

Please input keywords

Order

*Country

日本

アメリカ

中国

オーストラリア

シンガポール

イギリス

フランス

ドイツ

スイス

イタリア

カナダ

韓国

オランダ

ベルギー

スウェーデン

その他

*Province

*City

*Name

*Telephone

*Company

*Position

*Email

*Verification code

*Verification Code

B-luc EL4

Common name	B-luc EL4	Catalog number	310682
Aliases	NA	Disease	lymphoma
Organism	Mouse	Strain	C57BL/6
Tissue types	Lymphoma	Tissue	T lymphocyte

Description

This B-luc EL4 cell line expresses firefly luciferase as a marker of EL4 cells. Luminescence can be observed B-luc EL4 cells.

Application

B-luc EL4 cell line can be used to evaluate anti-cancer drugs in lymphoma in vivo.

Targeting strategy

Gene targeting strategy for B-luc EL4. The luciferase cDNA sequence with CAG promoter was inserted in the ROSA26 intron1 of wild-type EL4.

Phenotypic Analysis

from clipboard

Luminescence signal intensity of B-luc EL4 cells. Luminescence intensity was measured using the Bright-GloTM luciferase Assay (Promega, Cat E2610). B-luc EL4 cells have a strong luminescence signal. The 1-E2 clone of B-luc EL4 cells can be used in vivo experiments.

Quantitative imaging data & body weight changes

from clipboard

Tumor growth and in vivo imaging of B-luc EL4 cells. B-luc EL4 cells (2x10⁵) were injected by tail vein into C57BL/6 mice (female, 7-8 week-old, n=5). Signal intensity and body weight were measured twice a week. (A) Imaging was performed on days 0, 3, 6, 10, 13, 17, 20, 24, and 27, (B) Mice body weight (Mean ± SEM). B-luc EL4 cells can be used for in vivo efficacy evaluation.